United States· US:70518-4275_5a947dc5-7059-82ab-e063-6394a90af352
ADMELOG
A medicinal product containing insulin lispro, registered in United States by REMEDYREPACK INC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- INSULIN LISPRO
- Manufacturer
- REMEDYREPACK INC.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1170518-4275-0
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insulin lispro in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceHUMALOG 100 UI/ml KWIKPEN, solution injectableELI LILLY NEDERLAND BV (PAY-BAS)
- United KingdomAdmelog 100units/ml solution for injection 10ml vialsSanofi
- CzechiaBYSUMLOGGan & Lee Pharmaceuticals Europe GmbH, Düsseldorf
- FinlandBysumlogGan & Lee Pharmaceuticals Europe GmbH
- BelgiumBysumlog 100 U/mlGan & Lee Pharmaceuticals Europe
- SwedenBysumlog 100 E/ml Injektionsvätska, lösning i förfylld injektionspennaSandoz GmbH
- IcelandBysumlogGan & Lee Pharmaceuticals Europe GmbH
- NetherlandsBysumlog 100 eenheden/ml oplossing voor injectie in een voorgevulde penGan & Lee Pharmaceuticals Europe GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bysumlog, Humalog
- Liechtenstein · Bysumlog, Humalog
- Norway · Bysumlog, Humalog
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/70a36d0e-669f-4c89-a683-7cb4b1b7e108 GET /v1/drugs/70a36d0e-669f-4c89-a683-7cb4b1b7e108?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "100",
"substance": "INSULIN LISPRO",
"productndc": "70518-4275",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "U/mL",
"application_number": "BLA209196",
"marketing_category": "BLA"
}See everything about insulin lispro.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.